YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
3M Company's MMM Safety and Industrial segment remains a key growth driver, supported by broad-based demand across its major end markets. The segment continues to benefit from strength in industrial adhesives and tapes, electrical, industr…
Check out the companies making the biggest moves premarket: Haemonetics — The blood and plasma provider popped 8% after CSL expects to complete the rollout of Haemonetics' plasmapheresis platform across the U.S. by the end of 2027. Wolfspe…
3M Company's MMM shares have risen 12.9% in the past six months compared with the S&P 500 composite's growth of 30% and the industry's decline of 20.4%. Among its peers, Griffon Corporation GFF and Carlisle Companies Incorporated CSL share…
CSL (ASX:CSL) has put kidney and liver disease firmly in focus, committing an upfront US$355 million to partner with Alentis Therapeutics on lixudebart and agreeing to fund upcoming Phase 2 and 3 trials. CSL's move on lixudebart lands afte…
CSL (CSLLY [https://seekingalpha.com/symbol/CSLLY]) and Alentis Therapeutics have entered an exclusive global partnership to co-develop and co-promote lixudebart for rare kidney, liver, and other diseases. Under the agreement, CSL (CSL [ht…
Investing.com-- CSL Ltd (ASX:CSL) shares rose on Monday after the Australian healthcare company said it had agreed to pay up to $1.6 billion to jointly develop and commercialise an experimental treatment for rare kidney and liver diseases.…
Alentis to receive US$355 million initial payment and up to US$1.2 billion in commercial milestones, with global profits shared MELBOURNE, Australia and BASEL, Switzerland, Oct. 5, 2026 /PRNewswire/ -- CSL and Alentis Therapeutics today an…
HOLLY SPRINGS, N.C., Sept. 29, 2026 /PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL), today announced expanded availability of influenza vaccine in the United States following the successful completion of its 2026/27 manufacturing…
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fu…
Investors interested in stocks from the Diversified Operations sector have probably already heard of Sumitomo Corp. (SSUMY) and Carlisle (CSL). But which of these two stocks is more attractive to value investors? We'll need to take a close…
Building Materials Stocks Q2 Recap: Benchmarking Armstrong World (NYSE:AWI) The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a look at how building materials stocks fa…
2 Profitable Stocks with Solid Fundamentals and 1 We Avoid Even if a company is profitable, it doesn't always mean it's a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their…
3M Company MMM continues to face challenges in its Consumer business segment. The segment is experiencing sluggish demand across consumer retail markets, as cautious discretionary spending and reduced inventory levels at retailers weigh on…
CSL (ASX:CSL) has secured a multi-year Advance Purchase Agreement extension with the UK government for its Aujemflu vaccine. The UK will be the first country to commercially launch CSL Seqirus' adjuvanted, trivalent cell-based influenza va…
CSL Canada has expanded public reimbursement for ANDEMBRY® (garadacimab), its once-monthly hereditary angioedema prophylaxis, across Quebec, Alberta and key federal programs, following strong Phase 3 trial data and a nomination for the 202…
Reflecting On Building Materials Stocks' Q2 Earnings: Vulcan Materials (NYSE:VMC) As the Q2 earnings season wraps, let's dig into this quarter's best and worst performers in the building materials industry, including Vulcan Materials (NYSE…
Quebec became the first Canadian province to publicly reimburse ANDEMBRY®,1 followed by Alberta effective September 1, 2026, expanding provincial public access for eligible Canadians living with HAE.2 ANDEMBRY® is also covered through fede…
On 10 September 2026, Carlisle Companies held a board meeting at which director Jesse G. Singh resigned under the company's governance guidelines, the board size was set at six, and leadership, compensation, and governance matters were rev…
A Look Back at Building Materials Stocks' Q2 Earnings: Martin Marietta Materials (NYSE:MLM) Vs The Rest Of The Pack The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a…
3 of Wall Street's Favorite Stocks We Approach with Caution Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it's important to remain skeptical because analysts fa…
Q2 Building Materials Earnings Review: First Prize Goes to Carlisle (NYSE:CSL) Let's dig into the relative performance of Carlisle (NYSE:CSL) and its peers as we unravel the now-completed Q2 building materials earnings season. Traditionall…
Building Materials Stocks Q2 In Review: Tecnoglass (NYSE:TGLS) Vs Peers As the craze of earnings season draws to a close, here's a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at building…
Phase 3 study demonstrates benefits of the first influenza vaccine to combine three proven approaches to enhancing protection for older adults in a single vaccine. MAIDENHEAD, United Kingdom, Sept. 10, 2026 /PRNewswire/ -- CSL Seqirus, a b…
Phase 3 study demonstrates benefits of the first influenza vaccine to combine three proven approaches to enhancing protection for older adults in a single vaccine. MAIDENHEAD, United Kingdom, Sept. 11, 2026 /PRNewswire/ -- CSL Seqirus, a b…
Carlisle Companies Incorporated CSL has been witnessing solid momentum in the Construction Materials segment, supported by the healthy demand for reroofing products. Strength in the non-residential construction market in the United States…
Q2 Earnings Outperformers: Sherwin-Williams (NYSE:SHW) And The Rest Of The Building Materials Stocks Wrapping up Q2 earnings, we look at the numbers and key takeaways for the building materials stocks, including Sherwin-Williams (NYSE:SHW)…
3M Company's MMM shares have gained 9.1% over the past year, outperforming the Zacks Diversified Operations industry's decline of 26.4%. In contrast, the S&P 500 has increased 19.1%. The company's industry peers like Emerson Electric Co. E…
Building Materials Stocks Q2 Teardown: Resideo (NYSE:REZI) Vs The Rest Looking back on building materials stocks' Q2 earnings, we examine this quarter's best and worst performers, including Resideo (NYSE:REZI) and its peers. Traditionally,…
Investors looking for stocks in the Diversified Operations sector might want to consider either Sumitomo Corp. (SSUMY) or Carlisle (CSL). But which of these two stocks presents investors with the better value opportunity right now? Let's t…
3 Cash-Producing Stocks We're Skeptical Of While strong cash flow is a key indicator of stability, it doesn't always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak comp…
(Bloomberg) -- Australian earnings beats are outpacing misses for the first time in four years, defying a challenging economic backdrop and bolstering chances for a stalled stock rally to resume. Most Read from Bloomberg Apple Maps Renames…
National Presto Industries, Inc. NPK shares have climbed 44.5% in the past year against the industry's 26.4% decline. The company has outperformed other industry players, including GPGI, Inc. GPGI and Carlisle Companies Incorporated CSL. S…
3M Company's MMM Safety and Industrial segment continues to provide solid support to its overall growth, driven by broad-based demand across key end markets. The segment is seeing strength across industrial adhesives and tapes, electrical,…
(Bloomberg) -- The Trump administration has struck new drug pricing agreements with nine biotech and pharmaceutical companies including UCB SA, Bridgebio Pharma Inc. and Sun Pharmaceutical Industries Ltd. Most Read from Bloomberg Nvidia to…
It has been about a month since the last earnings report for Carlisle (CSL). Shares have lost about 2.5% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent negative trend continue leading u…
3M Company MMM is taking structural measures to improve operating efficiency and strengthen margins. The company has been reducing the size of its corporate center, streamlining its geographic footprint, simplifying its supply chain, align…